Cargando…

A Model-Based Method for Assessment of Salivary Gland and Planning Target Volume Dosimetry in Volumetric-Modulated Arc Therapy Planning on Head-and-Neck Cancer

This study examined the relationship of achievable mean dose and percent volumetric overlap of salivary gland with the planning target volume (PTV) in volumetric-modulated arc therapy (VMAT) plan in radiotherapy for a patient with head-and-neck cancer. The aim was to develop a model to predict the v...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Honglai, Cao, Yijian, Antone, Jeffrey, Riegel, Adam C., Ghaly, Maged, Potters, Louis, Jamshidi, Abolghassem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764180/
https://www.ncbi.nlm.nih.gov/pubmed/31576068
http://dx.doi.org/10.4103/jmp.JMP_19_19
Descripción
Sumario:This study examined the relationship of achievable mean dose and percent volumetric overlap of salivary gland with the planning target volume (PTV) in volumetric-modulated arc therapy (VMAT) plan in radiotherapy for a patient with head-and-neck cancer. The aim was to develop a model to predict the viability of planning objectives for both PTV coverage and organs-at-risk (OAR) sparing based on overlap volumes between PTVs and OARs, before the planning process. Forty patients with head-and-neck cancer were selected for this retrospective plan analysis. The patients were treated using 6 MV photons with 2-arc VMAT plan in prescriptions with simultaneous integrated boost in dose of 70 Gy, 63 Gy, and 58.1 Gy to primary tumor sites, high-risk nodal regions, and low-risk nodal regions, respectively, over 35 fractions. A VMAT plan was generated using Varian Eclipse (V13.6), in optimization with biological-based generalized equivalent uniform dose (gEUD) objective for OARs and targets. Target dose coverage (D(95), D(max), conformity index) and salivary gland dose (D(mean) and D(max)) were evaluated in those plans. With a range of volume overlaps between salivary glands and PTVs and dose constraints applied, results showed that dose D(95) for each PTV was adequate to satisfy D(95) >95% of the prescription. Mean dose to parotid <26 Gy could be achieved with <20% volumetric overlap with PTV(58) (parotid-PTV(58)). On an average, the D(mean) was seen at 15.6 Gy, 21.1 Gy, and 24.2 Gy for the parotid-PTV(58) volume at <5%, <10%, and <20%, respectively. For submandibular glands (SMGs), an average D(mean) of 27.6 Gy was achieved in patients having <10% overlap with PTV(58), and 36.1 Gy when <20% overlap. Mean doses on parotid and SMG were linearly correlated with overlap volume (regression R(2) = 0.95 and 0.98, respectively), which were statistically significant (P < 0.0001). This linear relationship suggests that the assessment of the structural overlap might provide prospective for achievable planning objectives in the head-and-neck plan.